| (EUR) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 364.25M | — |
| Operating expense | — | — |
| Net income | -57.94M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, YDO1.F returned +25.1% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -11.0% |
| 1 year | +25.1% |
| 5 years | +522.8% |
| 10 years | +4276.1% |
| All-time high | €511.60 (Nov 2025) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in YDO1.F would be worth today ›No. Madrigal Pharmaceuticals, Inc. has not paid a dividend in the past 12 months.
Madrigal Pharmaceuticals, Inc. is part of the Healthcare sector.
Madrigal Pharmaceuticals, Inc. has a market cap of 10.15B EUR, based on the latest quote.
